Articles with public access mandates - Nnennaya AjayiLearn more
Available somewhere: 10
Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January–March 2012)
NA Ajayi, CG Nwigwe, BN Azuogu, BN Onyire, EU Nwonwu, ...
International Journal of Infectious Diseases 17 (11), e1011-e1016, 2013
Mandates: German Research Foundation
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
H Tegally, JE San, M Cotten, M Moir, B Tegomoh, G Mboowa, DP Martin, ...
Science 378 (6615), eabq5358, 2022
Mandates: Bill & Melinda Gates Foundation, US Department of Defense, US National …
Widespread arenavirus occurrence and seroprevalence in small mammals, Nigeria
A Olayemi, A Oyeyiola, A Obadare, J Igbokwe, AS Adesina, F Onwe, ...
Parasites & vectors 11, 1-9, 2018
Mandates: German Research Foundation, European Commission
Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
IB Olawoye, PE Oluniyi, JU Oguzie, JN Uwanibe, TA Kayode, TJ Olumade, ...
Nature communications 14 (1), 811, 2023
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, Wellcome …
Early onset of neurological features differentiates two outbreaks of Lassa fever in Ebonyi state, Nigeria during 2017–2018
NM Chika-Igwenyi, RE Harrison, C Psarra, J Gil-Cuesta, M Gulamhusein, ...
PLoS neglected tropical diseases 15 (3), e0009169, 2021
Mandates: Department of International Development, UK, World Health Organization
Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria
C Ugwu, T Olumade, E Nwakpakpa, V Onyia, E Odeh, RO Duruiheoma, ...
Scientific Reports 12 (1), 22330, 2022
Mandates: US National Institutes of Health, UK Biotechnology and Biological Sciences …
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever
AT Olayinka, J Bourner, GO Akpede, J Okoeguale, C Abejegah, NA Ajayi, ...
PLoS Neglected Tropical Diseases 16 (1), e0010089, 2022
Mandates: Bill & Melinda Gates Foundation, Wellcome Trust
The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeutics
J Bourner, AP Salam, M Jaspard, A Olayinka, C Fritzell, B Goncalves, ...
Wellcome Open Research 8, 122, 2023
Mandates: Wellcome Trust
Immunological insights into COVID-19 in Southern Nigeria
CA Ugwu, O Alao, OG John, B Akinnawo, I Ajayi, O Odebode, I Bejide, ...
Frontiers in Immunology 15, 1305586, 2024
Mandates: Bill & Melinda Gates Foundation
Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics
J Bourner, M Vaillant, APA Salam, M Jaspard, C Fritzell, ST Jacob, ...
Emerging Infectious Diseases 31 (2), e240251, 2025
Mandates: Wellcome Trust
Publication and funding information is determined automatically by a computer program